29 Patent Results (22 families)

Patent Results

Make Note

Method For The Treatment Of Cerebral Ischaemia And Use Of Erythropoietin Or Erythropoietin Derivatives For The Treatment Of Cerebral Ischaemia

  • Published: Apr 7, 2009
  • Filed: Dec 13, 1999
  • Earliest Priority: Dec 14 1998
  • Family: 44
  • Cited Works: 100
  • Cited by: 32
  • Cites: 24
  • Additional Info: Cited Works Full text Published
  • Applicant: Ehrenreich Hannelore, Gleiter Christoph
Granted Patent
US 7514072 B1
033-648-424-609-266

Tissue Protective Cytokines For The Treatment And Prevention Of Sepsis And The Formation Of Adhesions

  • Published: Jan 12, 2010
  • Filed: Sep 29, 2004
  • Earliest Priority: Sep 29 2003
  • Family: 19
  • Cited Works: 99
  • Cited by: 3
  • Cites: 100
  • Additional Info: Cited Works Full text Published
  • Owner: Warren Pharmaceuticals Inc, Kenneth S. Warren Institute Inc. The
  • Applicant: Kenneth S Warren Inst Inc, Warren Pharmaceuticals Inc
Granted Patent
US 7645733 B2
030-149-293-578-352

Methods For Treatment Of Neurodegenerative Conditions By Peripherally Administered Erythropoietin

  • Published: Aug 12, 2008
  • Filed: Nov 21, 2000
  • Earliest Priority: Apr 13 1999
  • Family: 4
  • Cited Works: 100
  • Cited by: 17
  • Cites: 32
  • Additional Info: Cited Works Full text Published
  • Applicant: Kenneth S Warren Inst Inc
Granted Patent
US 7410941 B1
151-797-555-783-413

Methods For Treatment And Prevention Of Neuromuscular And Muscular Conditions By Peripherally Administered Erythropoietin

  • Published: Dec 18, 2007
  • Filed: Nov 21, 2000
  • Earliest Priority: Apr 13 1999
  • Family: 4
  • Cited Works: 102
  • Cited by: 64
  • Cites: 33
  • Additional Info: Cited Works Full text Published
  • Applicant: Kenneth S Warren Inst Inc
Granted Patent
US 7309687 B1
167-400-744-500-366

Modulation Of Excitable Tissue Function By Peripherally Administered Erythropoietin

  • Published: Mar 18, 2008
  • Filed: Nov 21, 2000
  • Earliest Priority: Apr 13 1999
  • Family: 2
  • Cited Works: 100
  • Cited by: 12
  • Cites: 31
  • Additional Info: Cited Works Full text Published
  • Applicant: Kenneth S Warren Inst Inc
Granted Patent
US 7345019 B1
131-043-787-653-11X

Erythropoietin Variants

  • Published: Nov 16, 2006
  • Filed: May 15, 2006
  • Earliest Priority: May 13 2005
  • Family: 20
  • Cited Works: 21
  • Cited by: 10
  • Cites: 9
  • Sequences: 63
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Charite Universitaetsmedizin, Meisel Andreas, Priller Josef, Bonnas Christel, Dirnagl Ulrich
Patent Application
WO 2006/120030 A1
002-394-200-757-831

Methods For Shp1 Mediated Neuroprotection

  • Published: Oct 31, 2006
  • Filed: Mar 11, 2003
  • Earliest Priority: Mar 11 2002
  • Family: 8
  • Cited Works: 63
  • Cited by: 4
  • Cites: 15
  • Sequences: 6
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Ortho-mcneil Pharmaceutical Inc
  • Applicant: Janssen Pharmaceutica Nv
Granted Patent
US 7129267 B2
191-303-589-723-986

Neuroprotective Peptides

  • Published: Aug 21, 2007
  • Filed: May 23, 2001
  • Earliest Priority: May 26 2000
  • Family: 2
  • Cited Works: 34
  • Cited by: 3
  • Cites: 26
  • Sequences: 49
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Ortho Mcneil Pharmaceutical Inc
  • Applicant: Ortho Mcneil Pharm Inc
Granted Patent
US 7259146 B2
194-816-734-589-684

Protection And Enhancement Of Erythropoietin-responsive Cells, Tissues And Organs

  • Published: Mar 11, 2003
  • Filed: Dec 29, 2000
  • Earliest Priority: Dec 29 2000
  • Family: 3
  • Cited Works: 102
  • Cited by: 139
  • Cites: 29
  • Additional Info: Cited Works Full text Published
  • Owner: Kenneth S. Warren Laboratories
  • Applicant: Kenneth S Warren Inst Inc
Granted Patent
US 6531121 B2
110-946-616-913-963

Treatment Of Neurological Dysfunction Comprising Fructopyranose Sulfamates And Erythropoietin

  • Published: Jun 21, 2005
  • Filed: Jan 24, 2002
  • Earliest Priority: Feb 02 2001
  • Family: 26
  • Cited Works: 67
  • Cited by: 25
  • Cites: 29
  • Additional Info: Cited Works Full text Published
  • Owner: Ortho-mcneil Pharmaceutical Inc
  • Applicant: Ortho Mcneil Pharm Inc
Granted Patent
US 6908902 B2
034-457-804-094-705
Preview
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}}
{{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password?
Feedback